In order to qualitatively assess tumour targeting and proliferation of MG-TNFα, bacteria were administered to Balb/C mice bearing CT26 tumours (i.v.)and monitored by BLI and immunofluorescence (IF) over time. The gene discussed is TNF; the disease is neoplasm.